Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.
This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
In December 2024, President Donald Trump’s nominee to lead the Department of Health and Human Services asserted that GLP-1 medications such as Ozempic ... Medicare is forbidden to cover weight ...
Novo Nordisk sells the drug semaglutide under the brands Ozempic for diabetes and Wegovy for weight loss. The company's ... to give the drugs a second try. Medicare, the federal health program ...
Languages: English and Farsi A majority of Americans approve of adults using weight-loss drugs like Ozempic ... that about half of Americans support Medicare and Medicaid covering weight-loss ...
More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands ... or “somewhat” favor having the federal programs Medicare and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback